Dov Engelstein

1.4k total citations
37 papers, 1.1k citations indexed

About

Dov Engelstein is a scholar working on Pulmonary and Respiratory Medicine, Urology and Surgery. According to data from OpenAlex, Dov Engelstein has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Urology and 9 papers in Surgery. Recurrent topics in Dov Engelstein's work include Bladder and Urothelial Cancer Treatments (8 papers), Urological Disorders and Treatments (6 papers) and Urinary Bladder and Prostate Research (6 papers). Dov Engelstein is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Urological Disorders and Treatments (6 papers) and Urinary Bladder and Prostate Research (6 papers). Dov Engelstein collaborates with scholars based in Israel, United States and Switzerland. Dov Engelstein's co-authors include C Servadio, Miriam Konichezky, Eliahu Mukamel, Anthony P. Albino, Jack Baniel, Andrea Salonia, Zvi Leib, M. Pavone‐Macaluso, Renzo Colombo and Alan N. Houghton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Urology.

In The Last Decade

Dov Engelstein

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dov Engelstein Israel 17 356 332 329 249 212 37 1.1k
Roberto Casella Switzerland 21 619 1.7× 448 1.3× 396 1.2× 162 0.7× 215 1.0× 50 1.2k
Pilar González‐Peramato Spain 19 557 1.6× 166 0.5× 555 1.7× 178 0.7× 91 0.4× 106 1.3k
Zenjiro Masaki Japan 16 244 0.7× 186 0.6× 251 0.8× 97 0.4× 112 0.5× 49 746
Jairam R. Eswara United States 15 344 1.0× 207 0.6× 321 1.0× 181 0.7× 204 1.0× 47 974
Timothy L. Weiland United States 11 253 0.7× 113 0.3× 216 0.7× 116 0.5× 107 0.5× 15 866
Constantin S. von Kaisenberg Germany 25 746 2.1× 158 0.5× 435 1.3× 367 1.5× 27 0.1× 75 2.2k
Roberta Lucianò Italy 22 585 1.6× 307 0.9× 428 1.3× 287 1.2× 163 0.8× 74 1.4k
M. Nurmi Finland 15 208 0.6× 441 1.3× 312 0.9× 134 0.5× 105 0.5× 47 918
Patrick F. Keane United Kingdom 17 310 0.9× 351 1.1× 151 0.5× 128 0.5× 238 1.1× 57 886
Dominique Baruch France 23 322 0.9× 255 0.8× 191 0.6× 73 0.3× 20 0.1× 69 1.6k

Countries citing papers authored by Dov Engelstein

Since Specialization
Citations

This map shows the geographic impact of Dov Engelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dov Engelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dov Engelstein more than expected).

Fields of papers citing papers by Dov Engelstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dov Engelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dov Engelstein. The network helps show where Dov Engelstein may publish in the future.

Co-authorship network of co-authors of Dov Engelstein

This figure shows the co-authorship network connecting the top 25 collaborators of Dov Engelstein. A scholar is included among the top collaborators of Dov Engelstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dov Engelstein. Dov Engelstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taha, Tarek, et al.. (2021). Re-do Boari flap for recurrent ureteric stricture. International braz j urol. 47(3). 670–673. 1 indexed citations
2.
Vjaters, Egils, et al.. (2018). First-in-man Safety and Efficacy of the ClearRing Implant for the Treatment of Benign Prostatic Hyperplasia. European Urology Focus. 6(1). 131–136. 9 indexed citations
3.
Colombo, Renzo, Andrea Salonia, Zvi Leib, M. Pavone‐Macaluso, & Dov Engelstein. (2010). Long‐term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin‐C alone as adjuvant treatment for non‐muscle‐invasive bladder cancer (NMIBC). British Journal of Urology. 107(6). 912–918. 154 indexed citations
4.
5.
Niv, Eva, et al.. (2005). Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus. International Journal of Impotence Research. 17(5). 431–436. 23 indexed citations
6.
Baniel, Jack, et al.. (2004). Treatment program for erectile dysfunction in patients with cardiovascular diseases. The American Journal of Cardiology. 93(6). 689–693. 11 indexed citations
7.
Abarbanel, Joseph, Dov Engelstein, Dov Lask, & Pinhas M. Livne. (2003). Urinary tract infection in men younger than 45 years of age: is there a need for urologic investigation?. Urology. 62(1). 27–29. 16 indexed citations
8.
Niv, Eva, et al.. (2002). Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate. International Journal of Impotence Research. 14(1). 38–43. 9 indexed citations
9.
Yossepowitch, Ofer, G Gillon, Jack Baniel, Dov Engelstein, & Pinhas M. Livne. (2001). THE EFFECT OF CHOLINERGIC ENHANCEMENT DURING FILLING CYSTOMETRY: CAN EDROPHONIUM CHLORIDE BE USED AS A PROVOCATIVE TEST FOR OVERACTIVE BLADDER?. The Journal of Urology. 165(5). 1441–1445. 17 indexed citations
10.
Yossepowitch, Ofer, et al.. (2000). Bladder neck involvement at radical prostatectomy: positive margins or advanced T4 disease?. Urology. 56(3). 448–452. 34 indexed citations
11.
Vazina, Amnon, Jack Baniel, Dov Engelstein, et al.. (2000). The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel. British Journal of Cancer. 83(4). 463–466. 47 indexed citations
12.
13.
Baniel, Jack, et al.. (1998). Intravesical bacillus Calmette-Guérin treatment for Stage T1 grade 3 transitional cell carcinoma of the bladder. Urology. 52(5). 785–789. 44 indexed citations
14.
Kessler, Oded, et al.. (1998). Management of Renal Angiomyolipoma:Analysis of 15 Cases. European Urology. 33(6). 572–575. 49 indexed citations
15.
Engelstein, Dov, et al.. (1997). A critical appraisal of vesicoureteral ref lux in long-term renal transplantation recipients: Prospective study. Transplantation Proceedings. 29(1-2). 136–137. 20 indexed citations
16.
Engelstein, Dov, Pinhas M. Livne, Maya Cohen, & C Servadio. (1996). Type ii ureteral triplication associated with ectopic ureter. Urology. 48(5). 786–788. 6 indexed citations
17.
Baniel, Jack, et al.. (1996). Penile edema and meatal ulceration after intravesical instillation with Bacillus Calmette-Guérin. Urology. 47(6). 932–934. 15 indexed citations
18.
19.
Morrison, Mark E., Vijayasaradhi Setaluri, Dov Engelstein, Anthony P. Albino, & Alan N. Houghton. (1993). A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.. The Journal of Experimental Medicine. 177(4). 1135–1143. 143 indexed citations
20.
Schoenfeld, Alex, Joseph Pardo, Dov Engelstein, Jardena Ovadia, & C Servadio. (1991). Bladder perforation by an intrauterine device. Journal of Clinical Ultrasound. 19(3). 175–177. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Casella Breakdown of academic impact, for papers by Pilar González‐Peramato Breakdown of academic impact, for papers by Zenjiro Masaki Breakdown of academic impact, for papers by Jairam R. Eswara Breakdown of academic impact, for papers by Timothy L. Weiland Breakdown of academic impact, for papers by Constantin S. von Kaisenberg Breakdown of academic impact, for papers by Roberta Lucianò Breakdown of academic impact, for papers by M. Nurmi Breakdown of academic impact, for papers by Patrick F. Keane Breakdown of academic impact, for papers by Dominique Baruch
Rankless by CCL
2026